US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 3.3500
  • +0.1300+4.04%
Close Jan 3 16:00 ET
  • 3.3500
  • 0.00000.00%
Post 19:58 ET
128.36MMarket Cap-2.04P/E (TTM)

Leap Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
28.54%18.35M
46.19%21M
-65.66%14.58M
57.08%85.94M
12.72%14.84M
-2.44%14.28M
-11.95%14.36M
300.70%42.45M
31.20%54.71M
17.35%13.17M
Selling and administrative expenses
-11.71%2.94M
-5.37%3.37M
-6.82%3.53M
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
-General and administrative expense
-11.71%2.94M
-5.37%3.37M
-6.82%3.53M
17.03%13.81M
7.77%3.14M
4.52%3.33M
24.62%3.56M
32.87%3.78M
9.59%11.8M
4.15%2.91M
Research and development costs
29.66%14.92M
61.07%17.89M
-70.99%11.3M
62.87%73.23M
5.90%11.69M
-4.95%11.5M
-20.94%11.1M
400.28%38.94M
39.82%44.97M
36.73%11.03M
Other operating expenses
190.07%499K
15.10%-253K
9.56%-246K
46.32%-1.1M
102.97%23K
15.03%-554K
49.23%-298K
-635.14%-272K
-67.29%-2.05M
-316.48%-775K
Operating profit
-28.54%-18.35M
-46.19%-21M
65.66%-14.58M
-57.08%-85.94M
-12.72%-14.84M
2.44%-14.28M
11.95%-14.36M
-300.70%-42.45M
-36.10%-54.71M
-21.41%-13.17M
Net non-operating interest income expense
-17.53%894K
-25.24%865K
-8.61%775K
362.34%4.03M
81.78%938K
210.60%1.08M
5,159.09%1.16M
5,400.00%848K
2,821.88%871K
17,100.00%516K
Non-operating interest income
-17.53%894K
-25.24%865K
-8.61%775K
335.35%4.03M
80.04%938K
201.11%1.08M
2,866.67%1.16M
16,860.00%848K
10,177.78%925K
10,320.00%521K
Non-operating interest expense
----
----
----
--0
----
----
----
----
31.71%54K
150.00%5K
Other net income (expense)
98.40%-8K
103.28%6K
93.77%-16K
182.07%499K
106.60%1.44M
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
Gain on sale of security
98.40%-8K
103.28%6K
93.77%-16K
99.84%-1K
34.86%940K
37.92%-501K
75.03%-183K
-209.36%-257K
-60.42%-608K
2,148.39%697K
Other non- operating income (expenses)
----
----
----
--500K
----
----
----
----
----
----
Income before tax
-27.54%-17.47M
-50.32%-20.13M
66.99%-13.82M
-49.52%-81.41M
-4.27%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.07%-54.45M
-10.57%-11.96M
Income tax
708K
0
0
0
712.50%147K
Net income
-32.71%-18.18M
-50.32%-20.13M
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
Net income continuous Operations
-32.71%-18.18M
-50.32%-20.13M
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
Minority interest income
Net income attributable to the parent company
-32.71%-18.18M
-50.32%-20.13M
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
Preferred stock dividends
Other preferred stock dividends
0
234K
0
0
Net income attributable to common stockholders
-32.71%-18.18M
-52.07%-20.36M
66.99%-13.82M
-49.12%-81.41M
-3.00%-12.47M
9.26%-13.7M
21.35%-13.39M
-303.46%-41.86M
-34.52%-54.6M
-12.18%-12.1M
Basic earnings per share
13.73%-0.44
42.86%-0.52
84.26%-0.51
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-260.00%-3.24
-2.55%-4.82
-10.00%-1.1
Diluted earnings per share
13.73%-0.44
42.86%-0.52
84.26%-0.51
17.43%-3.98
81.82%-0.2
61.65%-0.51
39.33%-0.91
-260.00%-3.24
-2.55%-4.82
-10.00%-1.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 28.54%18.35M46.19%21M-65.66%14.58M57.08%85.94M12.72%14.84M-2.44%14.28M-11.95%14.36M300.70%42.45M31.20%54.71M17.35%13.17M
Selling and administrative expenses -11.71%2.94M-5.37%3.37M-6.82%3.53M17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M
-General and administrative expense -11.71%2.94M-5.37%3.37M-6.82%3.53M17.03%13.81M7.77%3.14M4.52%3.33M24.62%3.56M32.87%3.78M9.59%11.8M4.15%2.91M
Research and development costs 29.66%14.92M61.07%17.89M-70.99%11.3M62.87%73.23M5.90%11.69M-4.95%11.5M-20.94%11.1M400.28%38.94M39.82%44.97M36.73%11.03M
Other operating expenses 190.07%499K15.10%-253K9.56%-246K46.32%-1.1M102.97%23K15.03%-554K49.23%-298K-635.14%-272K-67.29%-2.05M-316.48%-775K
Operating profit -28.54%-18.35M-46.19%-21M65.66%-14.58M-57.08%-85.94M-12.72%-14.84M2.44%-14.28M11.95%-14.36M-300.70%-42.45M-36.10%-54.71M-21.41%-13.17M
Net non-operating interest income expense -17.53%894K-25.24%865K-8.61%775K362.34%4.03M81.78%938K210.60%1.08M5,159.09%1.16M5,400.00%848K2,821.88%871K17,100.00%516K
Non-operating interest income -17.53%894K-25.24%865K-8.61%775K335.35%4.03M80.04%938K201.11%1.08M2,866.67%1.16M16,860.00%848K10,177.78%925K10,320.00%521K
Non-operating interest expense --------------0----------------31.71%54K150.00%5K
Other net income (expense) 98.40%-8K103.28%6K93.77%-16K182.07%499K106.60%1.44M37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K
Gain on sale of security 98.40%-8K103.28%6K93.77%-16K99.84%-1K34.86%940K37.92%-501K75.03%-183K-209.36%-257K-60.42%-608K2,148.39%697K
Other non- operating income (expenses) --------------500K------------------------
Income before tax -27.54%-17.47M-50.32%-20.13M66.99%-13.82M-49.52%-81.41M-4.27%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.07%-54.45M-10.57%-11.96M
Income tax 708K000712.50%147K
Net income -32.71%-18.18M-50.32%-20.13M66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M
Net income continuous Operations -32.71%-18.18M-50.32%-20.13M66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M
Minority interest income
Net income attributable to the parent company -32.71%-18.18M-50.32%-20.13M66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M
Preferred stock dividends
Other preferred stock dividends 0234K00
Net income attributable to common stockholders -32.71%-18.18M-52.07%-20.36M66.99%-13.82M-49.12%-81.41M-3.00%-12.47M9.26%-13.7M21.35%-13.39M-303.46%-41.86M-34.52%-54.6M-12.18%-12.1M
Basic earnings per share 13.73%-0.4442.86%-0.5284.26%-0.5117.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-260.00%-3.24-2.55%-4.82-10.00%-1.1
Diluted earnings per share 13.73%-0.4442.86%-0.5284.26%-0.5117.43%-3.9881.82%-0.261.65%-0.5139.33%-0.91-260.00%-3.24-2.55%-4.82-10.00%-1.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+14.12%
MicroStrategy
MSTR
+13.22%
Tesla
TSLA
+8.22%
Coinbase
COIN
+5.23%
Amazon
AMZN
+1.80%

Unlock the Full List